Stay updated on Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T23:53:44.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Summary
    The web page has updated its date information, adding several new dates in 2025 while removing older dates from 2024.
    Difference
    0.2%
    Check dated 2025-04-24T15:36:52.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the detailed study protocol for upadacitinib in treating atopic dermatitis, including participant criteria and study design. Additionally, the version number has been updated from v2.14.4 to v2.15.0.
    Difference
    6%
    Check dated 2025-04-17T11:08:51.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has updated the availability status of a product or service, indicating that it is now available, and has also revised the version number from v2.14.3 to v2.14.4.
    Difference
    0.1%
    Check dated 2025-04-10T05:52:30.000Z thumbnail image
  5. Check
    36 days ago
    No Change Detected
  6. Check
    72 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.3%
    Check dated 2025-02-25T19:40:35.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    0.3%
    Check dated 2025-02-10T11:11:20.000Z thumbnail image

Stay in the know with updates to Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page.